Carregant...
Tumor-Agnostic Drug Development
Therapies designed to target cancers that harbor specific molecular signatures have reshaped the landscape of oncologic drug development, and advances in next generation sequencing have led to an increase in the identification of these alterations across tumor types. Tumor-agnostic trial designs, su...
Guardat en:
| Publicat a: | Am Soc Clin Oncol Educ Book |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7506519/ https://ncbi.nlm.nih.gov/pubmed/30231313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_200831 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|